Maitreya Medicare Other Announcement
Maitreya Medicare Limited confirms there is no deviation in the utilization of IPO proceeds for the half year ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Maitreya Medicare other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements
Maitreya Medicare Limited confirms there is no deviation in the utilization of IPO proceeds for the half year ended September 30, 2026.
Maitreya Medicare Limited has filed a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Maitreya Medicare Limited submitted an exemption notice regarding the non-applicability of the Annual Secretarial Compliance Report for the financial year ended March 31, 2026. As an SME-listed entity on the NSE Emerge platform, the company is exempt from certain SEBI LODR compliance requirements under Regulation 15(2). This is a routine regulatory update for investors.
Maitreya Medicare Limited submitted a non-applicability certificate regarding Corporate Governance and Secretarial Compliance reports. As an NSE SME listed entity below specified thresholds, it is exempt from Regulation 27(2) and 24A for the period ended March 31, 2026. This is a routine regulatory compliance filing.
Maitreya Medicare Limited submitted its Structured Digital Database (SDD) Compliance Certificate for the financial year ended March 31, 2026. The certificate confirms that the company maintains a non-tamperable internal database to capture unpublished price-sensitive information (UPSI) in compliance with SEBI Insider Trading Regulations.
Maitreya Medicare Limited submitted its quarterly and annual compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and substituted in the register of members within prescribed timelines.